US20030206887A1
(en)
*
|
1992-05-14 |
2003-11-06 |
David Morrissey |
RNA interference mediated inhibition of hepatitis B virus (HBV) using short interfering nucleic acid (siNA)
|
JP2006507841A
(ja)
|
2002-11-14 |
2006-03-09 |
ダーマコン, インコーポレイテッド |
機能的siRNAおよび超機能的siRNA
|
ES2702942T3
(es)
|
2003-04-17 |
2019-03-06 |
Alnylam Pharmaceuticals Inc |
Agentes de ARNi modificados
|
EP1752536A4
(en)
*
|
2004-05-11 |
2008-04-16 |
Alphagen Co Ltd |
POLYNUCLEOTIDE CAUSING RNA INTERFERENCE AND METHOD OF REGULATING GENE EXPRESSION WITH THE USE OF THE SAME
|
EP1791567B1
(en)
|
2004-08-10 |
2015-07-29 |
Alnylam Pharmaceuticals Inc. |
Chemically modified oligonucleotides
|
CA2910760C
(en)
|
2007-12-04 |
2019-07-09 |
Muthiah Manoharan |
Targeting lipids
|
AU2014208251B2
(en)
|
2007-12-04 |
2016-07-14 |
Alnylam Pharmaceuticals, Inc. |
Carbohydrate conjugates as delivery agents for oligonucleotides
|
CN102083983B
(zh)
|
2008-08-01 |
2014-04-16 |
苏州瑞博生物技术有限公司 |
乙型肝炎病毒基因的小核酸干扰靶位点序列和小干扰核酸及组合物和应用
|
CA2750561C
(en)
*
|
2009-01-26 |
2017-10-10 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing apolipoprotein c-iii expression
|
US8975389B2
(en)
|
2009-03-02 |
2015-03-10 |
Alnylam Pharmaceuticals, Inc. |
Nucleic acid chemical modifications
|
NZ597504A
(en)
|
2009-06-15 |
2013-10-25 |
Alnylam Pharmaceuticals Inc |
Lipid formulated dsrna targeting the pcsk9 gene
|
AU2011203986C1
(en)
|
2010-01-08 |
2015-03-05 |
Ionis Pharmaceuticals, Inc. |
Modulation of angiopoietin-like 3 expression
|
CN102140461B
(zh)
|
2010-01-29 |
2012-12-05 |
苏州瑞博生物技术有限公司 |
小干扰核酸和药物组合物及其制药应用
|
CN102140458B
(zh)
|
2010-01-29 |
2013-05-22 |
苏州瑞博生物技术有限公司 |
小干扰核酸和药物组合物及其制药应用
|
EP2601204B1
(en)
|
2010-04-28 |
2016-09-07 |
Ionis Pharmaceuticals, Inc. |
Modified nucleosides and oligomeric compounds prepared therefrom
|
CN102344477B
(zh)
*
|
2010-07-27 |
2015-04-08 |
苏州瑞博生物技术有限公司 |
一种核苷酸和/或寡核苷酸及其制备方法
|
CA2807307C
(en)
|
2010-08-17 |
2021-02-09 |
Merck Sharp & Dohme Corp. |
Rna interference mediated inhibition of hepatitis b virus (hbv) gene expression using short interfering nucleic acid (sina)
|
US9290760B2
(en)
|
2010-09-15 |
2016-03-22 |
Alnylam Pharmaceuticals, Inc. |
Modified iRNA agents
|
CN103380113B
(zh)
|
2010-11-15 |
2018-03-30 |
生命科技公司 |
含胺的转染试剂及其制备和使用方法
|
US8501930B2
(en)
|
2010-12-17 |
2013-08-06 |
Arrowhead Madison Inc. |
Peptide-based in vivo siRNA delivery system
|
KR102481317B1
(ko)
|
2011-03-29 |
2022-12-26 |
알닐람 파마슈티칼스 인코포레이티드 |
Tmprss6 유전자의 발현을 억제하기 위한 조성물 및 방법
|
ES2923573T3
(es)
*
|
2011-06-21 |
2022-09-28 |
Alnylam Pharmaceuticals Inc |
Composiciones de ARNi de proteína 3 de tipo angiopoyetina (ANGPTL3) y métodos de uso de las mismas
|
MX342731B
(es)
|
2011-06-30 |
2016-10-11 |
Arrowhead Res Corp |
Composiciones y metodos para inhibir la expresion genica del virus de hepatitis b.
|
KR102272498B1
(ko)
|
2011-10-27 |
2021-07-06 |
메사추세츠 인스티튜트 오브 테크놀로지 |
약물 캡슐화 마이크로스피어를 형성할 수 있는, n-말단 상에 관능화된 아미노산 유도체
|
CN104717982B
(zh)
|
2012-08-06 |
2018-08-28 |
阿尔尼拉姆医药品有限公司 |
碳水化合物共轭物及其制备改进工艺
|
HUE035887T2
(hu)
|
2012-12-05 |
2018-05-28 |
Alnylam Pharmaceuticals Inc |
PCSK9 iRNS készítmények és eljárások azok alkalmazására
|
SI2970974T1
(sl)
|
2013-03-14 |
2017-12-29 |
Alnylam Pharmaceuticals, Inc. |
Komplementarna komponenta C5 sestavkov IRNA in postopki njene uporabe
|
EP2992009B1
(en)
|
2013-05-01 |
2020-06-24 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for modulating apolipoprotein (a) expression
|
US10246708B2
(en)
|
2013-05-06 |
2019-04-02 |
Alnylam Pharmaceuticals, Inc. |
Dosages and methods for delivering lipid formulated nucleic acid molecules
|
AU2014287002A1
(en)
*
|
2013-07-11 |
2016-02-11 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotide-ligand conjugates and process for their preparation
|
EP3087183B1
(en)
|
2013-12-24 |
2020-08-26 |
Ionis Pharmaceuticals, Inc. |
Modulation of angiopoietin-like 3 expression
|
EP3137091B1
(en)
|
2014-05-01 |
2020-12-02 |
Ionis Pharmaceuticals, Inc. |
Conjugates of modified antisense oligonucleotides and their use for modulating pkk expression
|
WO2015168589A2
(en)
|
2014-05-01 |
2015-11-05 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for modulating angiopoietin-like 3 expression
|
US20170114341A1
(en)
|
2014-06-06 |
2017-04-27 |
Solstice Biologics, Ltd. |
Polynucleotide constructs having bioreversible and non-bioreversible groups
|
SG10201913791QA
(en)
*
|
2014-08-20 |
2020-03-30 |
Alnylam Pharmaceuticals Inc |
Modified double-stranded rna agents
|
JOP20200092A1
(ar)
|
2014-11-10 |
2017-06-16 |
Alnylam Pharmaceuticals Inc |
تركيبات iRNA لفيروس الكبد B (HBV) وطرق لاستخدامها
|
EP3221451A1
(en)
*
|
2014-11-17 |
2017-09-27 |
Alnylam Pharmaceuticals, Inc. |
Apolipoprotein c3 (apoc3) irna compositions and methods of use thereof
|
JP2018509913A
(ja)
*
|
2015-03-17 |
2018-04-12 |
アローヘッド ファーマシューティカルズ インコーポレイテッド |
第xii因子の遺伝子発現を阻害するための組成物と方法
|
WO2016154127A2
(en)
*
|
2015-03-20 |
2016-09-29 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for treating hypertriglyceridemia
|
CN115927335A
(zh)
|
2015-04-13 |
2023-04-07 |
阿尔尼拉姆医药品有限公司 |
类血管生成素3(ANGPTL3)iRNA组合物及其使用方法
|
WO2016179342A2
(en)
|
2015-05-06 |
2016-11-10 |
Alnylam Pharmaceuticals, Inc. |
Factor xii (hageman factor) (f12), kallikrein b, plasma (fletcher factor) 1 (klkb1), and kininogen 1 (kng1) irna compositions and methods of use thereof
|
JP6715325B2
(ja)
*
|
2015-06-26 |
2020-07-01 |
スーチョウ リボ ライフ サイエンス カンパニー、リミテッドSuzhou Ribo Life Science Co., Ltd. |
siRNA、siRNAを含む医薬組成物及び結合体、並びにそれらの応用
|
US20180216114A1
(en)
|
2015-07-27 |
2018-08-02 |
Alnylam Pharmaceuticals, Inc. |
Xanthine dehydrogenase (xdh) irna compositions and methods of use thereof
|
KR20180038465A
(ko)
|
2015-08-07 |
2018-04-16 |
애로우헤드 파마슈티컬스 인코포레이티드 |
B형 간염 바이러스 감염에 대한 rnai 치료법
|
CN114939124A
(zh)
|
2015-08-25 |
2022-08-26 |
阿尔尼拉姆医药品有限公司 |
治疗前蛋白转化酶枯草杆菌蛋白酶kexin(pcsk9)基因相关障碍的方法和组合物
|
US10883107B2
(en)
|
2016-01-08 |
2021-01-05 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotide agents targeting factor XII (hageman factor) (F12) and methods of use thereof
|
JOP20170161A1
(ar)
|
2016-08-04 |
2019-01-30 |
Arrowhead Pharmaceuticals Inc |
عوامل RNAi للعدوى بفيروس التهاب الكبد ب
|
EP3500581A4
(en)
|
2016-08-17 |
2021-10-06 |
Solstice Biologics, Ltd. |
POLYNUCLEOTIDE CONSTRUCTS
|
CN108220293B
(zh)
|
2016-12-21 |
2021-09-24 |
苏州瑞博生物技术股份有限公司 |
一种小干扰核酸和药物组合物及其用途
|
CA3048661A1
(en)
|
2017-01-30 |
2018-08-02 |
Arrowhead Pharmaceuticals Inc. |
Compositions and methods for inhibition of factor xii gene expression
|
JP2022506517A
(ja)
|
2018-11-02 |
2022-01-17 |
アルブータス・バイオファーマー・コーポレイション |
標的指向化二価結合体
|